“CJC-1295” Does Not Always Mean the Same Molecule
Search for CJC-1295 peptide and one problem appears immediately:
CJC-1295 with DAC and CJC-1295 No DAC are frequently discussed as though they were interchangeable.
They are not.
SUNONE identifies its CJC-1295 NO DAC product as:
CJC-1295 Without DAC
Modified GRF 1-29
Mod GRF 1-29
and explicitly states that this material does not contain the Drug Affinity Complex modification.
That distinction matters when interpreting research.
The Best-Known Human CJC-1295 Data Are Mostly DAC Data
Classic human studies of CJC-1295 evaluated a long-acting GHRH analogue engineered to bind circulating albumin.
In healthy adults, that DAC-containing molecule produced prolonged increases in GH and IGF-1 lasting several days.
A separate human study found that GH pulsatility was preserved while basal GH and mean GH secretion increased after the long-acting CJC-1295 compound.
Those are real human data.
But they should not automatically be presented as human evidence for CJC-1295 No DAC / Modified GRF 1-29.
What Does the Evidence Say About No-DAC CJC-1295?
A 2026 peer-reviewed review reached an important conclusion:
CJC-1295 without DAC remains essentially uncharacterized in controlled human clinical literature.
The authors noted that many claims about physiologic GH pulsatility, body composition and performance are extrapolated from related GHRH compounds rather than directly demonstrated for the No-DAC material itself.
For scientifically responsible SEO content, that difference matters.
A page should not turn:
“related mechanism”
into:
“clinically proven outcome.”
Why the Naming Problem Matters for Procurement
FDA scientific materials have also discussed uncertainty around the terminology used for CJC-1295 with and without DAC.
That creates a practical question for laboratories:
What molecule is actually being supplied?
Professional buyers should verify:
Product identity — Is the material Modified GRF 1-29 / CJC-1295 No DAC?
DAC status — Does the supplied peptide contain a Drug Affinity Complex modification?
Molecular mass — Does analytical testing support the stated molecule?
HPLC purity — Is the purity result linked to the supplied batch?
Mass spectrometry — Is identity documentation available according to specification?
Batch COA — Does the certificate correspond to the actual shipment?
For this product category, terminology is not a minor marketing detail.
It defines the research material.
Positive and Negative CJC-1295 No DAC Reviews Are Hard to Interpret
Online discussions often report positive experiences involving sleep, recovery, strength or body-composition changes.
However, many of the most positive 2026 reports involve CJC-1295 No DAC combined with Ipamorelin, making it impossible to assign the reported outcome specifically to one component.
Negative anecdotes include headaches, dizziness, local discomfort, sleep problems and fluid-retention-type complaints.
These experiences are uncontrolled, product identity is generally unverified, and combination use is common.
They therefore cannot establish efficacy, safety or causality.
For professional research procurement, analytical documentation is more informative than testimonials.
SUNONE CJC-1295 NO DAC Research Peptide
SUNONE supplies CJC-1295 No DAC / Modified GRF 1-29 for qualified laboratory, analytical and biopharmaceutical research.
Current specifications include:
Synonyms: CJC-1295 Without DAC, Modified GRF 1-29, Mod GRF 1-29
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.9 g/mol
Purity: ≥99%, HPLC
Grade: Research Grade
Form: Lyophilized Solid
Storage: 2–8°C, protected from light
B2B Sizes: 5 mg and 10 mg
Documentation: COA, HPLC and MS documentation according to batch specification.
View SUNONE CJC-1295 NO DAC Specifications:
Looking for a CJC-1295 No DAC Supplier with COA?
For peptide laboratories, biotechnology companies and research distributors, the right sourcing question is not simply:
“Do you supply CJC-1295?”
The better question is:
“Which CJC-1295 molecule is this—and can you document its identity?”
If your organization is sourcing CJC-1295 No DAC, Modified GRF 1-29, Mod GRF 1-29 or related GHRH research peptides, SUNONE can provide current specifications, batch documentation, OEM/ODM options, MOQ and B2B quotation information.
Conclusion
The biggest research problem with CJC-1295 No DAC may not be the peptide itself.
It is the name.
Human CJC-1295 studies are frequently cited without clearly stating whether the investigated molecule contained DAC.
For professional research buyers, the solution is straightforward:
verify the DAC status, verify the molecular identity, verify the HPLC/MS data and verify the batch-specific COA.
The keyword may generate the search.
Molecular clarity should generate the inquiry.
This content is provided for scientific and educational purposes only. SUNONE research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame. Purchasers are responsible for complying with applicable laws and regulations in their jurisdiction.
Leave a Reply